Marksans Pharma informs about AGM

27 Sep 2019 Evaluate

Marksans Pharma has informed that the shareholders of the Company at the 27th Annual General Meeting (AGM) held on 26th September, 2019 has adopted the Standalone and Consolidated Audited Financial Statements of the Company for the financial year ended 31st March, 2019 together with the reports of the Board of Directors and the Auditors thereon; declared dividend of Rs 0.05 (i.e. 5%) on Equity Shares of Re 1 each face value and dividend of Rs 7.00 (i.e. 7%) on Redeemable Cumulative Preference Shares of Rs 100 each face value. The dividend will be paid on or after 4rd October, 2019; approved re-appointment of Sandra Saldanha (DIN: 00021023), who retired by rotation and being eligible, offered herself for re-appointment; approved appointment of Abhinna Sundar Mohanty (DIN: 00007995) as an Independent Director of the Company for a period of 5 consecutive years with effect from 11th July, 2019; and approved Marksans Employees Stock Option Scheme 2019.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×